Skip to main content

Atara Biotherapeutics IPO delayed by new test results

Atara Biotherapeutics postponed its expected Thursday IPO after it got new information about one of its drugs, according to a report from Thomson Reuters...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.